Chargement en cours...
Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
Background: Palliative chemotherapy has been the mainstay treatment for patients with recurrent or metastatic nasopharyngeal carcinoma (R/M-NPC). However, little is known about the efficacy and toxicity of nimotuzumab (NTZ) – a monoclonal antibody drug targeting epidermal growth factor receptor – pl...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
SAGE Publishing
2020-09-01
|
Collection: | Therapeutic Advances in Medical Oncology |
Accès en ligne: | https://doi.org/10.1177/1758835920953738 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|